A small catalytic DNA, known as the 10-23 DNA enzyme or deoxyribozyme, has
been shown to efficiently hydrolyze RNA at purine-pyrimidine (R-Y) junction
s in vitro. Although these potentially cleavable junctions are ubiquitous,
they are often protected from deoxyribozyme activity by RNA secondary struc
ture. We have developed a multiplex cleavage assay for screening the entire
length of a target RNA molecule for deoxyribozyme cleavage sites that are
efficient, both in terms of kinetics and accessibility. This strategy allow
ed us to simultaneously compare the RNA cleaving activity of 80 deoxyribozy
mes for a model target gene (HPV16 E6), and an additional 60 deoxyribozymes
against the rat c-myc target. The human papilloma virus (HPV) target was u
sed primarily to characterize the multiplex system and determine its validi
ty. The c-myc target, coupled with a smooth muscle cell proliferation assay
, allowed us to assess the relationship between in vitro cleavage efficienc
y and c-myc gene suppression in cell culture. The multiplex reaction approa
ch streamlines the process of revealing effective deoxyribozymes in a funct
ional assay and provides accessibility data that may also be applicable to
site selection for other hybridization-based agents.